vs
Side-by-side financial comparison of INNOVATIVE SOLUTIONS & SUPPORT INC (ISSC) and Xilio Therapeutics, Inc. (XLO). Click either name above to swap in a different company.
INNOVATIVE SOLUTIONS & SUPPORT INC is the larger business by last-quarter revenue ($21.8M vs $13.7M, roughly 1.6× Xilio Therapeutics, Inc.). Xilio Therapeutics, Inc. runs the higher net margin — 75.7% vs 18.6%, a 57.1% gap on every dollar of revenue. INNOVATIVE SOLUTIONS & SUPPORT INC produced more free cash flow last quarter ($7.0M vs $-2.1M).
Motorola Solutions, Inc., is an American technology company that provides safety and security products and services. Headquartered in Chicago, Illinois, the company provides critical communications, video security, and command center technologies, used by public safety agencies and enterprises. It was formed in 2011 by the division of Motorola, Inc., and is its legal successor; the former company's mobile phone division was spun off as Motorola Mobility, now part of Chinese technology company...
Xilio Therapeutics is a clinical-stage biotechnology company dedicated to developing novel tumor-selective immunotherapies for cancer treatment. Its product pipeline features candidates engineered to trigger anti-tumor immune responses specifically inside tumor microenvironments, reducing systemic toxicities, and it primarily targets oncology patient populations in North America and other global markets.
ISSC vs XLO — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.8M | $13.7M |
| Net Profit | $4.1M | $10.4M |
| Gross Margin | 54.5% | — |
| Operating Margin | 28.9% | -86.5% |
| Net Margin | 18.6% | 75.7% |
| Revenue YoY | 36.6% | — |
| Net Profit YoY | 451.4% | 179.1% |
| EPS (diluted) | $0.22 | $-3.74 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $21.8M | $13.7M | ||
| Q3 25 | $22.2M | $19.1M | ||
| Q2 25 | $24.1M | $8.1M | ||
| Q1 25 | $21.9M | $2.9M | ||
| Q4 24 | $16.0M | — | ||
| Q3 24 | $15.4M | — | ||
| Q2 24 | $11.8M | — | ||
| Q1 24 | $10.7M | — |
| Q4 25 | $4.1M | $10.4M | ||
| Q3 25 | $7.1M | $-16.3M | ||
| Q2 25 | $2.4M | $-15.8M | ||
| Q1 25 | $5.3M | $-13.3M | ||
| Q4 24 | $736.2K | — | ||
| Q3 24 | $3.2M | — | ||
| Q2 24 | $1.6M | — | ||
| Q1 24 | $1.2M | — |
| Q4 25 | 54.5% | — | ||
| Q3 25 | 63.2% | — | ||
| Q2 25 | 35.5% | — | ||
| Q1 25 | 51.4% | — | ||
| Q4 24 | 41.4% | — | ||
| Q3 24 | 55.4% | — | ||
| Q2 24 | 53.4% | — | ||
| Q1 24 | 52.0% | — |
| Q4 25 | 28.9% | -86.5% | ||
| Q3 25 | 37.0% | -10.1% | ||
| Q2 25 | 14.6% | -177.7% | ||
| Q1 25 | 31.8% | -472.7% | ||
| Q4 24 | 8.4% | — | ||
| Q3 24 | 28.4% | — | ||
| Q2 24 | 17.3% | — | ||
| Q1 24 | 15.3% | — |
| Q4 25 | 18.6% | 75.7% | ||
| Q3 25 | 32.0% | -85.4% | ||
| Q2 25 | 10.1% | -196.0% | ||
| Q1 25 | 24.3% | -452.7% | ||
| Q4 24 | 4.6% | — | ||
| Q3 24 | 20.7% | — | ||
| Q2 24 | 13.2% | — | ||
| Q1 24 | 11.3% | — |
| Q4 25 | $0.22 | $-3.74 | ||
| Q3 25 | $0.40 | $-0.11 | ||
| Q2 25 | $0.14 | $-0.16 | ||
| Q1 25 | $0.30 | $-0.18 | ||
| Q4 24 | $0.04 | — | ||
| Q3 24 | $0.18 | — | ||
| Q2 24 | $0.09 | — | ||
| Q1 24 | $0.07 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.3M | $137.5M |
| Total DebtLower is stronger | $23.8M | — |
| Stockholders' EquityBook value | $68.7M | $35.3M |
| Total Assets | $109.9M | $154.7M |
| Debt / EquityLower = less leverage | 0.35× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.3M | $137.5M | ||
| Q3 25 | $2.7M | $103.8M | ||
| Q2 25 | $601.8K | $121.6M | ||
| Q1 25 | $1.2M | $89.1M | ||
| Q4 24 | $604.6K | — | ||
| Q3 24 | $539.0K | — | ||
| Q2 24 | $521.0K | — | ||
| Q1 24 | $574.1K | — |
| Q4 25 | $23.8M | — | ||
| Q3 25 | $24.4M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $68.7M | $35.3M | ||
| Q3 25 | $64.6M | $-8.1M | ||
| Q2 25 | $56.8M | $7.1M | ||
| Q1 25 | $53.5M | $10.7M | ||
| Q4 24 | $47.8M | — | ||
| Q3 24 | $46.6M | — | ||
| Q2 24 | $43.2M | — | ||
| Q1 24 | $41.4M | — |
| Q4 25 | $109.9M | $154.7M | ||
| Q3 25 | $103.4M | $133.7M | ||
| Q2 25 | $91.8M | $133.8M | ||
| Q1 25 | $89.9M | $103.7M | ||
| Q4 24 | $81.3M | — | ||
| Q3 24 | $82.4M | — | ||
| Q2 24 | $59.8M | — | ||
| Q1 24 | $57.6M | — |
| Q4 25 | 0.35× | — | ||
| Q3 25 | 0.38× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | $-2.0M |
| Free Cash FlowOCF − Capex | $7.0M | $-2.1M |
| FCF MarginFCF / Revenue | 32.3% | -15.3% |
| Capex IntensityCapex / Revenue | 5.1% | 0.7% |
| Cash ConversionOCF / Net Profit | 2.01× | -0.19× |
| TTM Free Cash FlowTrailing 4 quarters | $12.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.2M | $-2.0M | ||
| Q3 25 | $3.0M | $-17.5M | ||
| Q2 25 | $7.2M | $-14.5M | ||
| Q1 25 | $1.3M | $29.0M | ||
| Q4 24 | $1.8M | — | ||
| Q3 24 | $445.3K | — | ||
| Q2 24 | $934.1K | — | ||
| Q1 24 | $201.1K | — |
| Q4 25 | $7.0M | $-2.1M | ||
| Q3 25 | $2.0M | — | ||
| Q2 25 | $3.5M | $-14.9M | ||
| Q1 25 | $-267.7K | $29.0M | ||
| Q4 24 | $1.6M | — | ||
| Q3 24 | $299.5K | — | ||
| Q2 24 | $730.8K | — | ||
| Q1 24 | $75.4K | — |
| Q4 25 | 32.3% | -15.3% | ||
| Q3 25 | 8.8% | — | ||
| Q2 25 | 14.6% | -184.0% | ||
| Q1 25 | -1.2% | 988.3% | ||
| Q4 24 | 9.9% | — | ||
| Q3 24 | 1.9% | — | ||
| Q2 24 | 6.2% | — | ||
| Q1 24 | 0.7% | — |
| Q4 25 | 5.1% | 0.7% | ||
| Q3 25 | 4.5% | 0.0% | ||
| Q2 25 | 15.3% | 5.0% | ||
| Q1 25 | 7.1% | 0.8% | ||
| Q4 24 | 1.6% | — | ||
| Q3 24 | 0.9% | — | ||
| Q2 24 | 1.7% | — | ||
| Q1 24 | 1.2% | — |
| Q4 25 | 2.01× | -0.19× | ||
| Q3 25 | 0.42× | — | ||
| Q2 25 | 2.95× | — | ||
| Q1 25 | 0.24× | — | ||
| Q4 24 | 2.50× | — | ||
| Q3 24 | 0.14× | — | ||
| Q2 24 | 0.60× | — | ||
| Q1 24 | 0.17× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ISSC
| Products | $13.6M | 62% |
| Services | $8.2M | 38% |
XLO
Segment breakdown not available.
